Mostrar el registro sencillo

dc.contributor.authorHernández Hernández, José Luis es_ES
dc.contributor.authorLisa, Martaes_ES
dc.contributor.authorNapal, Jose Javieres_ES
dc.contributor.authorCórdoba, Anaes_ES
dc.contributor.authorOlmos Martínez, José Manuel es_ES
dc.contributor.authorRuiz, Sheilaes_ES
dc.contributor.authorSierra, Isabeles_ES
dc.contributor.authorGarcía Sardina, Rominaes_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-05-16T14:55:38Z
dc.date.available2022-05-16T14:55:38Z
dc.date.issued2017es_ES
dc.identifier.issn2578-7160es_ES
dc.identifier.urihttp://hdl.handle.net/10902/24839
dc.description.abstractPurpose Our aim was a) to compare serum Hcy levels in patients with RVO and population-based controls, and b) to evaluate whether hyperhomocysteinemia is a risk factor for RVO. Patients and methods Prospective case-control study of all patients diagnosed with RVO at a tertiary-care hospital, and age-and sex-matched controls taking part in a population-based prospective cohort in the same geographic area. Differences in serum Hcy between both groups were analyzed by a general linear model adjusted for age, body mass index (BMI), glomerular filtration rate (GFR), hypertension, dyslipidemia, diabetes, tobacco use and alcohol intake. Besides, we tested the relationship between hyperhomocysteinemia (> 15 µmol/L) and RVO, by a stepwise logistic regression analysis. Results RVO patients (n = 85) had a higher prevalence of hypertension (p = 0.002), diabetes (p = 0.008), and dyslipidemia (p = 0.04) than controls (n = 82). Adjusted median Hcy levels were higher in RVO patients (p < 0.0001). Adjusted OR for hyperhomocysteinemia were 4.4 (95% CI, 2.0-9.3; p < 0.0001) in the overall sample, and 2.6 (95% CI, 1.04-6.6; p = 0.04) and 6.1 (95% CI, 1.7-21.6; p = 0.005) for men and women, respectively. Conclusion Patients with RVO have higher serum Hcy levels than age- and sex-matched population-based controls. Hyperhomocysteinemia seems to be a risk factor for RVO, independent of age, BMI, GFR and classical vascular risk factors.es_ES
dc.format.extent6 p.es_ES
dc.language.isoenges_ES
dc.publisherScholarly Pageses_ES
dc.rightsAttribution 4.0 International*
dc.rights©Los autores*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJ Ophthalmic Res Ocular Care 2017, 1(1):12-17es_ES
dc.subject.otherRetinal vein occlusiones_ES
dc.subject.otherHomocysteinees_ES
dc.subject.otherHyperhomocysteinemiaes_ES
dc.subject.otherRisk factores_ES
dc.titleSerum Homocysteine Levels in Patients with Retinal Vein Occlusion in a Spanish Populationes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://www.doi.org/10.36959/936/560es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.36959/936/560es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International